Datadog, Inc. (DDOG) Insider Transactions

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares sold pursuant to a 10b5-1 plan dated December 11, 2025.

F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.91 to $230.67. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.02 to $231.88. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.17 to $233.06. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.19 to $234.11. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.48 to $235.26. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.49 to $236.39. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $236.87 to $237.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References: F1, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares sold pursuant to a 10b5-1 plan dated December 11, 2025.

F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.91 to $230.67. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.02 to $231.88. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.17 to $233.06. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.19 to $234.11. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.48 to $235.26. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.49 to $236.39. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $236.87 to $237.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References: F1, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F15

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

F3 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F4 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.73 to $228.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.83 to $229.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.83 to $230.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.83 to $231.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.84 to $232.83. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.85 to $233.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.85 to $234.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.86 to $235.85. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.90 to $236.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

References: F13

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Obstler Children 2019 Trust FBO the Reporting Person's child, of which the Reporting Person's spouse is Trustee. Obstler Children 2019 Trust FBO the Reporting Person's child and Obstler Children 2019 Trust FBO the Reporting Person's other child are separate trusts for the benefit of the Reporting Person's children with substantially identical terms.

F3 Shares are held directly by Obstler Children 2019 Trust FBO the Reporting Person's other child, of which the Reporting Person's spouse is Trustee. See Footnote 2.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Obstler Children 2019 Trust FBO the Reporting Person's child, of which the Reporting Person's spouse is Trustee. Obstler Children 2019 Trust FBO the Reporting Person's child and Obstler Children 2019 Trust FBO the Reporting Person's other child are separate trusts for the benefit of the Reporting Person's children with substantially identical terms.

F3 Shares are held directly by Obstler Children 2019 Trust FBO the Reporting Person's other child, of which the Reporting Person's spouse is Trustee. See Footnote 2.

References:

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Obstler Children 2019 Trust FBO the Reporting Person's child, of which the Reporting Person's spouse is Trustee. Obstler Children 2019 Trust FBO the Reporting Person's child and Obstler Children 2019 Trust FBO the Reporting Person's other child are separate trusts for the benefit of the Reporting Person's children with substantially identical terms.

F3 Shares are held directly by Obstler Children 2019 Trust FBO the Reporting Person's other child, of which the Reporting Person's spouse is Trustee. See Footnote 2.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F1, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F1, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F14, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F13, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F12, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F11, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F10, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F9, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F8, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F7, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F5, F6, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F1, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F3, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.

F3 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.

F4 Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.

F5 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.63 to $228.58. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.67 to $229.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.67 to $230.66. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.70 to $231.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.70 to $232.69. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.72 to $233.68. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.72 to $234.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.72 to $235.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F14 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.82 to $236.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F15 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

F16 Shares are held by Reporting Person's spouse.

References: F1, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

F3 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F4 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.73 to $228.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.83 to $229.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.83 to $230.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.83 to $231.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.84 to $232.83. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.85 to $233.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.85 to $234.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.86 to $235.85. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.90 to $236.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

References: F1, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

F3 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F4 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.73 to $228.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.83 to $229.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.83 to $230.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.83 to $231.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.84 to $232.83. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.85 to $233.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.85 to $234.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.86 to $235.85. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.90 to $236.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

References: F3, F12, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

F3 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F4 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.73 to $228.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.83 to $229.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.83 to $230.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.83 to $231.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.84 to $232.83. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.85 to $233.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.85 to $234.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.86 to $235.85. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.90 to $236.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

References: F3, F11, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.

F2 The Shares are held by The Callahan-Thernstrom Family Trust, of which Reporting Person is Trustee.

F3 Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.

F4 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $227.73 to $228.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $228.83 to $229.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $229.83 to $230.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $230.83 to $231.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $231.84 to $232.83. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $232.85 to $233.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $233.85 to $234.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F11 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $234.86 to $235.85. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $235.90 to $236.65. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F13 Represents the number of shares underlying Restricted Stock Units ("RSUs") granted pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. The RSUs vest on the earlier of (A) the Company's next annual meeting of stockholders and (B) June 15, 2027, in each case, subject to the Reporting Person's continuous service to the Issuer through the vesting date.

References: F3, F10, F2